Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
What will members gain?

Download Now: New Slide Deck Programme

Previous slide decks focused on landmark studies which used a monoclonal antibody approach to inhibit PCSK9. The next in this series discusses inclisiran, a small interfering RNA therapy, which prevents production of PCSK9 at its primary source in the liver.

Find out more »
Most viewed

Hot Topics

13th Closed Virtual Meeting of the Editorial Board of PCSK9 Forum


Targets for LDL cholesterol: What have we learned from the trials?

Prof. Greg G. Schwartz discusses evidence from ODYSSEY OUTCOMES which supports the LDL cholesterol targets recommended for very high-risk patients by the 2019 ESC/EAS lipid guidelines.
Watch the webcast

Cost-effectiveness of PCSK9 inhibitors: A coming of age?

Dr. Kirsten Bibbins-Domingo and Prof. Dhruv S. Kazi discuss how cost-effectiveness analyses guided pricing for PCSK9 monoclonal antibodies in the USA. Initial high prices were counterproductive to uptake: will the situation be different for inclisiran?
Watch the webcast

From the Editors

Paediatric familial hypercholesterolaemia attracts new focus

Dr Albert Wiegman, Amsterdam University Medical Center, The Netherlands discusses the latest findings that have highlighted familial hypercholesterolaemia in children.

Read the report


Other related reports:

Professor Santos discusses HAUSER-RCT
Watch the video

Safety of LDL lowering in FH children
Read the report

EAS Consensus Panel on paediatric FH
Watch the video

ACC 2017

Meet our Editorial Board

View all our Editorial Board Prof John ChapmanResearch Professor at the University of Pierre and Marie Curie Prof Henry GinsbergDirector, Irving Institute for Clinical and Translational Research Dr Michel FarnierClinician based at Point Medical, Dijon, France Prof Frederick RaalDirector, Carbohydrate & Lipid Metabolism Research Unit Prof Anthony WierzbickiConsultant in Metabolic Medicine/Chemical Pathology